Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China : A 30‐week, double‐blind, phase 3a, randomized trial

Cited by (110)

Items 101–110 of 110

1. Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Psychological Well‐Being and Depressive Symptoms: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
   Tsung-Hsuan Hung, Chyi-Rong Chen, Chih‐Wei Hsu, Andre F. Carvalho, Brendon Stubbs, Ping‐Tao Tseng, Liang‐Jen Wang, Paul‐Yang Lin · 2026 · Human Psychopharmacology Clinical and Experimental
2. Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials
   Francesco Zaccardi, Vanita R. Aroda, Ecenur Guder Arslan, Lars Bardtrum, Jonathan Goldney, Erik Ising, Prachi Priyadarshini, Tommy Slater, Melanie Jane Davies · 2026 · Diabetes Obesity and Metabolism
3. The effect of GLP-1 receptor agonists on osteoarthritis risk in individuals with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized controlled trials
   Limin Zhou, Peiyang Wu, Yongxiang Xu, Baocheng Xie · 2026 · Acta Diabetologica
4. Cardiovascular outcomes of semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis
   Zhou Xiao-yu, Qi Wu, Hao-lan Lu, Jia-Jie Xie, Yu‐Fan Zhang, Yong Xu, Man Guo, Fang‐Yuan Teng · 2026 · Diabetology & Metabolic Syndrome
5. Comparative cardiovascular efficacy of antidiabetic therapies in type 2 diabetes: a systematic review and network meta-analysis of randomized trials
   Donya Mohammadi, Behnam Sadeghirad, Mohammad Aziz Rasouli, Lotfollah Saed, Hamid Reza Baradaran, Yousef Moradi · 2026 · Diabetology & Metabolic Syndrome
6. Effect of tirzepatide and semaglutide on blood pressure: A systematic review and meta-analysis
   Qing-Xin Chen, Zhou Xiao-yu, Qi Wu, Jia-Jie Xie, Yong Xu, Fang‐Yuan Teng, Man Guo · 2026 · Endocrine
7. Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
   Amparo Ortiz-Seller, José Tomás Real, Esteban Jesús Morcillo, J.L. Ortiz · 2026 · Survey of Ophthalmology
8. Cost-utility analysis of loxenatide versus DPP-4 inhibitors in Chinese patients with type 2 diabetes at high cardiovascular risk
   Longbing Lai, Fengning Chuan, Qiuhong Huang · 2026 · Frontiers in Public Health
9. Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
   Yuanyuan Zhong, Xing Tan, Ling Zhang, Cangui Wu · 2026 · Frontiers in Pharmacology
10. Combined Semaglutide and Sodium–Glucose Cotransporter-2 Inhibitor Use and Metabolic Outcomes in Chinese Adults With Diabetes: Post Hoc Analysis
    Shanshan Wang, BIXUAN DONG, Zewei Shen · 2026 · Diabetes Therapy